KNBIF Stock Overview - The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
PNK:KNBIF

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 27, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$KNBIF N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Kane Biotech Inc. Loading... Loading...
Sector Name Loading... N/A

Related

NTIINeurobiological Technologies, Inc.0.0%
PHGUFPharming Group N.V.0.0%
HESGHealth Sciences Group, Inc.900.0%
MMIRFMedMira Inc.0.0%
OCTHFOxford Cannabinoid Technologies Holdings Plc0.0%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue0M0M0M1M1M2M1M2M3M0M
Growth Rate-149.7%133.9%323.0%-51.1%234.5%-20.8%19.8%66.0%-94.4%
EBITDA-1M-2M-3M-3M-3M-3M-4M-4M-3M-4M
EBITDA Margin-3,518.4%-1,608.3%-1,027.3%-252.1%-611.8%-202.3%-271.9%-264.3%-102.9%-2,406.0%
Net Income-2M-2M-3M-3M-3M-1M-4M-5M-4M-5M
NI Margin-3,854.3%-1,634.4%-1,041.3%-269.1%-644.1%-56.7%-277.0%-286.4%-145.8%-3,379.0%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.